Leonteq Securities’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Other funds holding ALLO
Leonteq Securities's ALLO Position: Q3 2026 in Review
Leonteq Securities held its Allogene Therapeutics (ALLO) position steady in Q3 2026 at 351 shares worth $562. The position accounts for ﹤0.01% of the portfolio, ranked #1214.
Leonteq Securities first reported a position in ALLO in Q4 2020 and has held it in 16 quarters since. The position peaked at $288K in Q4 2020. 141 funds tracked by Wall St. Rank hold ALLO as of Q3 2026.
- Leonteq Securities held 351 shares of Allogene Therapeutics worth $562 as of Q3 2026.
- Leonteq Securities left its Allogene Therapeutics share count unchanged in Q3 2026.
- Allogene Therapeutics made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #1214 holding.
- Leonteq Securities first reported a position in Allogene Therapeutics in Q4 2020 and has held it in 16 quarters since.
- Leonteq Securities's Allogene Therapeutics position peaked at $288K in Q4 2020.
- 141 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.